🔗 Share this article Individuals Discontinuing Anti-Obesity Injections Gain Back Pounds Far More Rapidly Compared to Dieters Weight management involves ongoing approaches. Fresh analysis suggests that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise plans. Published data in a prominent medical journal shows that while obese people often shed a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping. "Users using such treatments should be cognizant of the danger of rapid rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb. That rate of regain implies a return to original mass within about a year and a half. Comparing Therapies The analysis, which examined dozens of trials involving thousands of participants, contrasted the outcomes of these new drugs with other pills. The team note that individuals who lose weight through lifestyle changes alone typically have a more gradual weight regain—approximately 0.1 kg a month—after stopping. The Reason for the Fast Rebound Experts believe the mechanism of the injections explains the accelerated weight return. The injections mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness. "Sustained high doses of GLP-1 concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert. "Discontinuation of this medication leads to hunger is unsuppressed, making overeating a significant risk." An Ongoing Condition? Medical guidelines advise the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications. Professionals say that, due to the high risk of weight regain, the treatment should be considered ongoing. This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term nature of excess weight," comparing it to managing conditions like hypertension. User Accounts Users who have discontinued the medication report a sudden return of hunger. "It felt as if a switch activating and you become starving," recalled an individual. This difficulty is exacerbated if users have not developed lasting dietary or behavioural modifications during therapy. Growing Interest Figures show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow. Adoption is more common among women compared to males. The middle-aged age group shows the highest level of interest. A large proportion obtain the drugs through private prescriptions rather than public health services. Ultimately, clinicians emphasize that while these medications are potent agents for shedding pounds, they are not a permanent solution and lasting health benefits hinges on ongoing behavioural changes.
Weight management involves ongoing approaches. Fresh analysis suggests that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise plans. Published data in a prominent medical journal shows that while obese people often shed a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping. "Users using such treatments should be cognizant of the danger of rapid rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb. That rate of regain implies a return to original mass within about a year and a half. Comparing Therapies The analysis, which examined dozens of trials involving thousands of participants, contrasted the outcomes of these new drugs with other pills. The team note that individuals who lose weight through lifestyle changes alone typically have a more gradual weight regain—approximately 0.1 kg a month—after stopping. The Reason for the Fast Rebound Experts believe the mechanism of the injections explains the accelerated weight return. The injections mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness. "Sustained high doses of GLP-1 concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert. "Discontinuation of this medication leads to hunger is unsuppressed, making overeating a significant risk." An Ongoing Condition? Medical guidelines advise the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications. Professionals say that, due to the high risk of weight regain, the treatment should be considered ongoing. This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term nature of excess weight," comparing it to managing conditions like hypertension. User Accounts Users who have discontinued the medication report a sudden return of hunger. "It felt as if a switch activating and you become starving," recalled an individual. This difficulty is exacerbated if users have not developed lasting dietary or behavioural modifications during therapy. Growing Interest Figures show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow. Adoption is more common among women compared to males. The middle-aged age group shows the highest level of interest. A large proportion obtain the drugs through private prescriptions rather than public health services. Ultimately, clinicians emphasize that while these medications are potent agents for shedding pounds, they are not a permanent solution and lasting health benefits hinges on ongoing behavioural changes.